Skip to main content
Top
Published in: Diabetologia 8/2004

01-08-2004 | Observation

Screening of depression in patients with diabetes mellitus

Authors: I. Rakovac, R. J. Gfrerer, W. Habacher, S. Seereiner, P. Beck, A. Risse, B. Bauer, T. R. Pieber, the Forum for Quality Systems in Diabetes Care (FQSD)

Published in: Diabetologia | Issue 8/2004

Login to get access

Excerpt

To the Editor: The link between depression and diabetes, late complications and glycaemic control is well established [1, 2, 3]. In routine care, a considerable proportion of patients with depression remains undetected and untreated [4, 5]. As diabetes requires self management, depression leads to a higher risk of diabetic late complications. The WHO (five) Well-Being Index (WB5) is a short screening instrument for the detection of depression in the general population. This instrument is also recommended in the WHO DiabCare Basic Information Sheet (BIS). WB5 was developed within the DepCare [6] project as a first-line low-mood screening instrument for depression. It is a short five-item questionnaire, whereby every answer is given a score between 0 and 5, yielding a raw score of between 0 and 25. A raw score below 13 indicates poor well-being and is considered to be an indicator of depression, which should be confirmed using the Major (ICD-10) Depression Inventory and through specific patient interviews [6]. WB5 has been evaluated in elderly patients, and showed adequate internal and external validity [7]. …
Literature
1.
go back to reference Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078PubMed Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078PubMed
2.
go back to reference Groot M de, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed Groot M de, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed
3.
go back to reference Lustman PJ, Anderson RJ, Freedland KE, Groot M de, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942PubMed Lustman PJ, Anderson RJ, Freedland KE, Groot M de, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942PubMed
4.
go back to reference Gerber PD, Barrett J, Barrett J, Manheimer E, Whiting R, Smith R (1989) Recognition of depression by internists in primary care: a comparison of internist and “gold standard” psychiatric assessments. J Gen Intern Med 4:7–13PubMed Gerber PD, Barrett J, Barrett J, Manheimer E, Whiting R, Smith R (1989) Recognition of depression by internists in primary care: a comparison of internist and “gold standard” psychiatric assessments. J Gen Intern Med 4:7–13PubMed
5.
go back to reference Thompson C, Kinmonth AL, Stevens L et al. (2000) Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 355:185–191CrossRefPubMed Thompson C, Kinmonth AL, Stevens L et al. (2000) Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 355:185–191CrossRefPubMed
7.
go back to reference Bonsignore M, Barkow K, Jessen F, Heun R (2001) Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci 251 [Suppl 2]:1127–1131 Bonsignore M, Barkow K, Jessen F, Heun R (2001) Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci 251 [Suppl 2]:1127–1131
Metadata
Title
Screening of depression in patients with diabetes mellitus
Authors
I. Rakovac
R. J. Gfrerer
W. Habacher
S. Seereiner
P. Beck
A. Risse
B. Bauer
T. R. Pieber
the Forum for Quality Systems in Diabetes Care (FQSD)
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1467-7

Other articles of this Issue 8/2004

Diabetologia 8/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.